CIM
XBI icon

Calvert Investment Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Calvert Investment Management’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-61,168
Closed -$3.16M – 809
2016
Q1 		$3.16M Buy
+61,168
New +$3.18M 0.14% 148

Other funds holding XBI

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Calvert Investment Management's XBI Position: Q2 2016 in Review

Calvert Investment Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2016, closing a stake of 61,168 shares — an estimated $3.16M sold.

Calvert Investment Management first reported a position in XBI in Q1 2016 and held it in 1 quarter. The position peaked at $3.16M in Q1 2016. 201 funds tracked by Wall St. Rank hold XBI as of Q2 2016.

  • Calvert Investment Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2016 after selling out during the quarter.
  • Calvert Investment Management sold 61,168 State Street SPDR S&P Biotech ETF shares in Q2 2016, an estimated $3.16M.
  • Calvert Investment Management first reported a position in State Street SPDR S&P Biotech ETF in Q1 2016 and held it in 1 quarter.
  • Calvert Investment Management's State Street SPDR S&P Biotech ETF position peaked at $3.16M in Q1 2016.
  • 201 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2016.

Based on Calvert Investment Management's 13F filing for Q2 2016, filed 4 Aug 2016.